Re: 2 directors Investing? Never invest simply because a Director 'buys' shares..that's my advice innit.
Re: 36p Willy 123, there's a very simple answer to this, in that this is a SETS traded stock where prices are governed by various market participants including traders and market professionals as well as the market makers. Other than the sell order at 36p, given the very high risk of a huge gap up to the upside at the open when there is news on a settlement, none are prepared to leave sell orders on the book overnight, or in this particular case the weekend. The 36p order does however give an indication of how high some seeing this going on news.ATB,T
Re: Oxus Gold Comp In this context this letter from Robert Amsterdam provides enough comfort for this investor:[link] worth a read imo.T
BROKER report forgot to ask, where can i find the latest broker target price for sar?
Re: patent granted yet we are drifting back down
Re: LoL _ Blood transfusion, Life suppor... But it's not the same is it? If Minty has registered a 'Ltd' and the name change is a 'plc'? Recollect that there was at one time an RMRI Ltd and an RMRI Plc. In fact, could I not go today to Co House and register what the General Meeting resolution is proposing as the new Enegi incarnation?
multibagger by Dec 2015 for me, OXS, JLP and WRES will have huge potential to multibag by end of 2015.OXS can easily 30p plus on awards, which can come anytime.JLP awaiting licence news, for its 4bn platinum mine. can easily trading 20p plus on licence. nevertheless, hopefully JLP will also start to make its move next week, because platinum is making huge recovery since last week and JLP got the RNS intraday on Friday and not many would have seen it. WRES also awaiting its mining licence and worth 3p (sp now only 0.6p)better be in all three !
WRES another to watch is WRES. CEO target 3p as per webcast and awaiting licence news, JV already in discussion. can hopefully multibag soon
300p by results on 23 November i says Belfast/London/Boston - Kainos Group plc (KNOS), the UK-based provider of IT services, will announce its Interim results for the six months ended 30 September 2015 on Monday 23 November 2015.
Shore Capital From Citywire:"Tate & Lyle on track but no upgrade yetConfidence is growing in sugar maker Tate & Lyle (TATE) after a more stable period of trading.Shore Capital analyst Darren Shirley reiterated his hold recommendation but has no target price on the stock following a six-month trading update to 30 September. The shares fell 1.8% to 569p yesterday.After a series of downgrades through full year 2014 and full year 2015, it is pleasing to see a more stable period of trading, he said, noting the speciality food ingredients arm was on track to deliver extra capacity and sucralose is more robust that expected.Tate & Lyle stock has had a strong Q3 2015, we believe both reflecting growing confidence that the group performance has stabilised and the potential for a return to growth in full year 2016 we believe [the] update supports such expectation though do not see sufficient positive news to move the shares on, as such we reiterate our hold stance. "
Berenberg From Citywire:"Synthomer: more to come from the chemicals makerChemicals makers Synthomer (SYNTS) is a buy for Berenberg thanks to potential for expansion in latex glove manufacturing and mergers and acquisitions (M&A).Berenberg analyst Sebastian Bray initiated coverage of the stock with a buy recommendation and a target price of 400p. The shares rose 3.3% to 340.6p yesterday.Synthomer is the worlds leading supplier of nitrile latex, which is used for the manufacturer of disposable gloves. The disposable market has shown a compound annual growth rate of c.8% over the last decade and we forecast growth of 9% per year to 2017 as healthcare provision in emerging markets improves, he said.Synthomer also enjoys market-leading positions in speciality chemicals geared to construction in fast-growing parts of Asia and the Middle East, and is implementing a cost-savings programme of c.£9 million a year by 2016.He added that the company has stated ambition for large M&A, with at least £660 million available for deals.Synthomer has performed well over the last few months and has re-rated significantly We believe there is more to come."
Liberum From Citywire:"Flybe covers the cost of one more surplus aircraftAirline Flybe (FLYB) has struck new deals with two airports that will cover the cost of one of its surplus aircraft.Liberum analyst Gerald Khoo retained his buy recommendation with a target price of 120p. The shares rose half a penny to 77.5p yesterday.An agreement with Exeter and Norwich airports allows Flybe to cover the cost of one more of its surplus E195 aircraft, he said.The deal sees the airports provide financial support for eight routes to five destinations. Eight of the surplus aircraft have now been dealt with, leaving management seeking solutions for the remaining six. There is no impact on our estimates or valuation, but it is nonetheless positive to see progress on an issue that has weighed on investor sentiment. "
IC Tip From 22/9/15:"IC VIEW:HaloSource is reliant on commercial partnerships, but it is clear that the emerging players in the $15bn water purification industry are clamouring for its technology. Liberum believes the company will increase revenues 30 per cent a year until 2017, by which point it expects cash profits of $2.6m and EPS of 0.8¢, thanks in part to $106m of tax credits amassed during the company's lossmaking years. The broker has set a target price of 40p equates based on and enterprise-value-to-2016-sales ratio of 2. A steady growth in drinking water target markets in China and India, coupled with increased product awareness, could provide significant long-term upside. Buy."
letter to Tethys LETTER BELOW EMAILED TO TETHYS TODAY. I WILL POST ANY REPLY RECEIVED.Dear Sir/MadamI am a shareholder in Tethys Petroleum, and am concerned that we have not made the payment for the September cash call issued by the Bokhtar Operating Company in connection with Tethys' interest in the Bokhtar PSC in Tajikistan.I am aware of yesterday's improved offer from Olisol that included an immediate investment of US $1.28 million upon the execution of a letter of intent relating to the Offer to allow Tethys to remedy an outstanding default on its Tajikstan license.As a matter of urgency, I wish the company to enter into a dialogue with Olisol concerning yesterday's improved offer. If this is not the intention of the company, I feel it is imperative that shareholders are informed of the reasons for not doing so.I await your earliest response.Yours faithfullyXXXXX
Re: Oxus Gold Comp I thought it was the Uzbek's that blocked the Chinese consortium deal, though this isn't at all clear in the following RNS's.[link]
Latest from the Community...
Latest from the Community...
Latest from the Community...